# Codexis, Inc.: financial statements, quarterly

CDXS · Nasdaq · CIK 1200375 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cdxs.md) · [Financials](/companies/cdxs/financials.md) · [Filings](/companies/cdxs/filings.md) · [Insiders](/companies/cdxs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cdxs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [9.3](/filings/0001200375-24-000027.md) | [26.6 d](/filings/0001200375-26-000006.md) | [17.1](/filings/0001200375-25-000006.md) | [8.0](/filings/0001200375-25-000012.md) | [12.8](/filings/0001200375-25-000016.md) | [21.5 d](/filings/0001200375-26-000006.md) | [7.5](/filings/0001200375-26-000012.md) | [15.3](/filings/0001200375-26-000019.md) | [8.6](/filings/0001200375-25-000016.md) | [38.9 d](/filings/0001200375-26-000006.md) | [15.2](/filings/0001200375-26-000012.md) | [14.9](/filings/0001200375-26-000019.md) |
| Cost of revenue | $m | [2.2](/filings/0001200375-24-000027.md) | [2.9 d](/filings/0001200375-26-000006.md) | [4.9](/filings/0001200375-25-000006.md) | [3.5](/filings/0001200375-25-000012.md) | [4.3](/filings/0001200375-25-000016.md) | [3.7 d](/filings/0001200375-26-000006.md) | [2.7](/filings/0001200375-26-000012.md) | [2.1](/filings/0001200375-26-000019.md) | [2.5](/filings/0001200375-25-000016.md) | [2.0 d](/filings/0001200375-26-000006.md) | [2.1](/filings/0001200375-26-000012.md) | [3.5](/filings/0001200375-26-000019.md) |
| Research and development | $m | [13.7](/filings/0001200375-24-000027.md) | [11.2 d](/filings/0001200375-26-000006.md) | [11.2](/filings/0001200375-25-000006.md) | [11.4](/filings/0001200375-25-000012.md) | [11.5](/filings/0001200375-25-000016.md) | [12.1 d](/filings/0001200375-26-000006.md) | [12.9](/filings/0001200375-26-000012.md) | [13.8](/filings/0001200375-26-000019.md) | [13.9](/filings/0001200375-25-000016.md) | [11.7 d](/filings/0001200375-26-000006.md) | [11.4](/filings/0001200375-26-000012.md) | [11.7](/filings/0001200375-26-000019.md) |
| Selling, general and administrative | $m | [12.3](/filings/0001200375-24-000027.md) | [12.2 d](/filings/0001200375-26-000006.md) | [12.9](/filings/0001200375-25-000006.md) | [15.7](/filings/0001200375-25-000012.md) | [13.6](/filings/0001200375-25-000016.md) | [13.0 d](/filings/0001200375-26-000006.md) | [12.4](/filings/0001200375-26-000012.md) | [12.3](/filings/0001200375-26-000019.md) | [11.2](/filings/0001200375-25-000016.md) | [11.2 d](/filings/0001200375-26-000006.md) | [9.8](/filings/0001200375-26-000012.md) | [10.9](/filings/0001200375-26-000019.md) |
| Operating income | $m | [(32.1)](/filings/0001200375-24-000027.md) | [0.3 d](/filings/0001200375-26-000006.md) | [(11.9)](/filings/0001200375-25-000006.md) | [(22.7)](/filings/0001200375-25-000012.md) | [(16.6)](/filings/0001200375-25-000016.md) | [(7.3) d](/filings/0001200375-26-000006.md) | [(20.5)](/filings/0001200375-26-000012.md) | [(12.9)](/filings/0001200375-26-000019.md) | [(18.9)](/filings/0001200375-25-000016.md) | [10.6 d](/filings/0001200375-26-000006.md) | [(8.0)](/filings/0001200375-26-000012.md) | [(11.2)](/filings/0001200375-26-000019.md) |
| Income tax | $m | [0.0](/filings/0001200375-24-000027.md) | [0.0 d](/filings/0001200375-26-000006.md) | [0.0](/filings/0001200375-25-000006.md) | [0.0](/filings/0001200375-25-000012.md) | [0.0](/filings/0001200375-25-000016.md) | [0.0 d](/filings/0001200375-26-000006.md) | [0.0](/filings/0001200375-26-000012.md) | [0.0](/filings/0001200375-26-000019.md) | [0.0](/filings/0001200375-25-000016.md) | [0.0 d](/filings/0001200375-26-000006.md) | [0.0](/filings/0001200375-26-000012.md) | [0.0](/filings/0001200375-26-000019.md) |
| Net income | $m | [(34.9)](/filings/0001200375-24-000027.md) | [(7.2) d](/filings/0001200375-26-000006.md) | [(11.5)](/filings/0001200375-25-000006.md) | [(22.8)](/filings/0001200375-25-000012.md) | [(20.6)](/filings/0001200375-25-000016.md) | [(10.4) d](/filings/0001200375-26-000006.md) | [(20.7)](/filings/0001200375-26-000012.md) | [(13.3)](/filings/0001200375-26-000019.md) | [(19.6)](/filings/0001200375-25-000016.md) | [9.6 d](/filings/0001200375-26-000006.md) | [(8.7)](/filings/0001200375-26-000012.md) | [(12.0)](/filings/0001200375-26-000019.md) |
| Diluted EPS | $ per share | [(0.50)](/filings/0001200375-24-000027.md) | not reported | [(0.16)](/filings/0001200375-25-000006.md) | [(0.32)](/filings/0001200375-25-000012.md) | [(0.29)](/filings/0001200375-25-000016.md) | not reported | [(0.25)](/filings/0001200375-26-000012.md) | [(0.16)](/filings/0001200375-26-000019.md) | [(0.22)](/filings/0001200375-25-000016.md) | not reported | [(0.10)](/filings/0001200375-26-000012.md) | [(0.13)](/filings/0001200375-26-000019.md) |
| Basic EPS | $ per share | [(0.50)](/filings/0001200375-24-000027.md) | not reported | [(0.16)](/filings/0001200375-25-000006.md) | [(0.32)](/filings/0001200375-25-000012.md) | [(0.29)](/filings/0001200375-25-000016.md) | not reported | [(0.25)](/filings/0001200375-26-000012.md) | [(0.16)](/filings/0001200375-26-000019.md) | [(0.22)](/filings/0001200375-25-000016.md) | not reported | [(0.10)](/filings/0001200375-26-000012.md) | [(0.13)](/filings/0001200375-26-000019.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [74.6](/filings/0001200375-24-000027.md) | [65.1](/filings/0001200375-26-000006.md) | [58.0](/filings/0001200375-25-000006.md) | [18.6](/filings/0001200375-25-000012.md) | [37.5](/filings/0001200375-25-000016.md) | [19.3](/filings/0001200375-26-000006.md) | [18.3](/filings/0001200375-26-000012.md) | [26.8](/filings/0001200375-26-000019.md) | [25.4](/filings/0001200375-25-000016.md) | [50.8](/filings/0001200375-26-000019.md) | [36.6](/filings/0001200375-26-000012.md) | [27.2](/filings/0001200375-26-000019.md) |
| Current assets | $m | [103](/filings/0001200375-23-000033.md) | [93.5](/filings/0001200375-25-000003.md) | [108](/filings/0001200375-24-000015.md) | [91.4](/filings/0001200375-24-000022.md) | [113](/filings/0001200375-24-000027.md) | [98.8](/filings/0001200375-26-000006.md) | [77.8](/filings/0001200375-25-000006.md) | [88.7](/filings/0001200375-25-000012.md) | [76.2](/filings/0001200375-25-000016.md) | [96.8](/filings/0001200375-26-000019.md) | [79.6](/filings/0001200375-26-000012.md) | [71.9](/filings/0001200375-26-000019.md) |
| Total assets | $m | [154](/filings/0001200375-23-000033.md) | [137](/filings/0001200375-25-000003.md) | [150](/filings/0001200375-24-000015.md) | [132](/filings/0001200375-24-000022.md) | [148](/filings/0001200375-24-000027.md) | [149](/filings/0001200375-26-000006.md) | [129](/filings/0001200375-25-000006.md) | [138](/filings/0001200375-25-000012.md) | [124](/filings/0001200375-25-000016.md) | [148](/filings/0001200375-26-000019.md) | [129](/filings/0001200375-26-000012.md) | [120](/filings/0001200375-26-000019.md) |
| Current liabilities | $m | [38.4](/filings/0001200375-23-000033.md) | [35.8](/filings/0001200375-25-000003.md) | [29.1](/filings/0001200375-24-000015.md) | [30.5](/filings/0001200375-24-000022.md) | [35.1](/filings/0001200375-24-000027.md) | [23.6](/filings/0001200375-26-000006.md) | [20.9](/filings/0001200375-25-000006.md) | [15.2](/filings/0001200375-25-000012.md) | [18.5](/filings/0001200375-25-000016.md) | [25.3](/filings/0001200375-26-000019.md) | [14.9](/filings/0001200375-26-000012.md) | [23.5](/filings/0001200375-26-000019.md) |
| Total liabilities | $m | [62.9](/filings/0001200375-23-000033.md) | [49.9](/filings/0001200375-25-000003.md) | [70.3](/filings/0001200375-24-000015.md) | [70.6](/filings/0001200375-24-000022.md) | [74.8](/filings/0001200375-24-000027.md) | [82.1](/filings/0001200375-26-000006.md) | [79.3](/filings/0001200375-25-000006.md) | [82.6](/filings/0001200375-25-000012.md) | [85.4](/filings/0001200375-25-000016.md) | [97.3](/filings/0001200375-26-000019.md) | [86.1](/filings/0001200375-26-000012.md) | [87.1](/filings/0001200375-26-000019.md) |
| Long-term debt | $m | not reported | [0.0](/filings/0001200375-25-000003.md) | [28.1](/filings/0001200375-24-000015.md) | [28.4](/filings/0001200375-24-000022.md) | [28.6](/filings/0001200375-24-000027.md) | [28.9](/filings/0001200375-26-000006.md) | [29.2](/filings/0001200375-25-000006.md) | [39.4](/filings/0001200375-25-000012.md) | [39.7](/filings/0001200375-25-000016.md) | [40.1](/filings/0001200375-26-000019.md) | [40.5](/filings/0001200375-26-000012.md) | [33.8](/filings/0001200375-26-000019.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001200375-26-000019.md) | not reported | [7.1](/filings/0001200375-26-000019.md) |
| Shareholders' equity | $m | [91.5](/filings/0001200375-24-000027.md) | [86.6](/filings/0001200375-26-000006.md) | [79.3](/filings/0001200375-25-000012.md) | [61.4](/filings/0001200375-25-000016.md) | [73.4](/filings/0001200375-25-000016.md) | [66.9](/filings/0001200375-26-000019.md) | [49.6](/filings/0001200375-26-000019.md) | [55.6](/filings/0001200375-26-000019.md) | [38.5](/filings/0001200375-25-000016.md) | [50.5](/filings/0001200375-26-000019.md) | [43.2](/filings/0001200375-26-000019.md) | [33.0](/filings/0001200375-26-000019.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(16.3) d](/filings/0001200375-24-000027.md) | [(11.0) d](/filings/0001200375-26-000006.md) | [(7.8)](/filings/0001200375-25-000006.md) | [(12.2) d](/filings/0001200375-25-000012.md) | [(13.0) d](/filings/0001200375-25-000016.md) | [(16.5) d](/filings/0001200375-26-000006.md) | [(13.8)](/filings/0001200375-26-000012.md) | [(18.0) d](/filings/0001200375-26-000019.md) | [(7.7) d](/filings/0001200375-25-000016.md) | [20.1 d](/filings/0001200375-26-000006.md) | [(13.2)](/filings/0001200375-26-000012.md) | [(9.6) d](/filings/0001200375-26-000019.md) |
| Capital expenditure | $m | [0.7 d](/filings/0001200375-24-000027.md) | [(0.4) d](/filings/0001200375-26-000006.md) | [1.1](/filings/0001200375-25-000006.md) | [0.4 d](/filings/0001200375-25-000012.md) | [1.0 d](/filings/0001200375-25-000016.md) | [1.8 d](/filings/0001200375-26-000006.md) | [1.3](/filings/0001200375-26-000012.md) | [2.5 d](/filings/0001200375-26-000019.md) | [0.2 d](/filings/0001200375-25-000016.md) | [0.5 d](/filings/0001200375-26-000006.md) | [0.2](/filings/0001200375-26-000012.md) | [0.9 d](/filings/0001200375-26-000019.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [65.4](/filings/0001200375-23-000033.md) | [65.9](/filings/0001200375-24-000015.md) | [67.6](/filings/0001200375-24-000022.md) | [69.5](/filings/0001200375-24-000027.md) | [69.9](/filings/0001200375-25-000006.md) | [70.4](/filings/0001200375-25-000012.md) | [72.0](/filings/0001200375-25-000016.md) | [82.4](/filings/0001200375-26-000012.md) | [85.4](/filings/0001200375-26-000019.md) | [90.3](/filings/0001200375-25-000016.md) | [90.8](/filings/0001200375-26-000012.md) | [91.1](/filings/0001200375-26-000019.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 109,505,765 at 2026-08-06, from the cover of the [10-Q filed 2026-08-11](/filings/0001200375-26-000019.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.